FDA Inspection
Devalingam Mahalingam, M.D., Ph.D.Devalingam Mahalingam, M.D., Ph.D. – FDA Inspection, Oct 18, 2024
Record Details
This FDA Inspection record concerns Devalingam Mahalingam, M.D., Ph.D., with an inspection on October 18, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 24dfb723-1578-492f-ae7e-621f0dfd2a55
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1252477
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 50.27(b)(2)Short form: Oral presentation/signing
- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.